The JPMorgan Growth Advantage strategy retains its Above Average People and Process ratings because of its deep investment resources, research synergy, and flexibility. A drop in the Morningstar Medalist Rating of some share classes isn’t attributable to reduced conviction in the strategy’s People or Process ratings but instead reflects a change in the way Morningstar calculates the excess return opportunity for funds.
This best-ideas strategy benefits from a deep and accomplished roster of analysts and portfolio managers. As an all-cap offering aiming to beat the Russell 3000 Growth Index, it harvests and combines 60-plus top picks from JPMorgan Large Cap Growth, JPMorgan Mid Cap Growth, and JPMorgan Small Cap Growth. The various teams supporting these strategies, as well as former lead manager Tim Parton, deserve credit for consistently identifying their better ideas for inclusion in this vehicle over the years. It has outperformed a combination of the underlying strategies weighted in proportion to this strategy’s market-cap breakout. J.P. Morgan’s talented core research team also offers insights that contribute to this strategy.
Manager Felise Agranoff is now leading the charge. Though she has only held the top spot for a bit over a year, she has an experienced partner in comanager Larry Lee and a bounty of support from the firm’s expansive research team, particularly in large-cap equity. Agranoff’s background in mid-cap equity plays a key role given the portfolio’s meaningful stake in that segment. While greater exposure to mid-caps hasn’t helped over the past couple of years versus the benchmark, it may yield benefits in other market environments.
The US mutual fund’s February 2025 reclassification as nondiversified is a positive regulatory development that will afford Agranoff and Lee more leeway to express their views on the largest constituents in the Russell 3000 Growth index.
Overall, this remains a good choice when accessed through cheaper vehicles or share classes.